Novel peanut-specific human IgE monoclonal antibodies may uncover new therapeutic targets for peanut allergy - Earth News Report
It is estimated that around 10% of the US population has peanut allergies, a medical emergency that can be treated but not cured. Compared to those without allergies, these individuals are at a greater risk of anaphylaxis. Hence, there is a need to develop novel therapies to treat peanut and other food allergies. A recent Frontiers
